Previous Article | Next Article 
Molecular and Cellular Biology, December 1999, p. 8302-8313, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Yap1p Activates Gene Transcription in an Oxidant-Specific
Fashion
Sean T.
Coleman,
Eric A.
Epping,
Susanne M.
Steggerda,
and
W. Scott
Moye-Rowley*
Department of Physiology and Biophysics,
University of Iowa, Iowa City, Iowa 52242
Received 14 April 1999/Returned for modification 25 May
1999/Accepted 25 August 1999
 |
ABSTRACT |
Positive regulation of gene expression by the yeast
Saccharomyces cerevisiae transcription factor Yap1p is
required for normal tolerance of oxidative stress elicited by the
redox-active agents diamide and H2O2. Several
groups have provided evidence that a cluster of cysteine residues in
the extreme C terminus of the factor are required for normal modulation
of Yap1p by oxidant challenge. Deletion of this C-terminal
cysteine-rich domain (c-CRD) produces a protein that is highly active
under both stressed and nonstressed conditions and is constitutively
located in the nucleus. We have found that a variety of different c-CRD
mutant proteins are hyperactive in terms of their ability to confer
diamide tolerance to cells but fail to provide even normal levels of
H2O2 resistance. Although the c-CRD mutant
forms of Yap1p activate an artificial Yap1p-responsive gene to the same
high level in the presence of either diamide or
H2O2, these mutant factors confer
hyperresistance to diamide but hypersensitivity to
H2O2. To address this discrepancy, we have
examined the ability of c-CRD mutant forms of Yap1p to activate
expression of an authentic target gene required for
H2O2 tolerance, TRX2. When assayed
in the presence of c-CRD mutant forms of Yap1p, a TRX2-lacZ
fusion gene fails to induce in response to
H2O2. We have also identified a second
cysteine-rich domain, in the N terminus (n-CRD), that is required for
H2O2 but not diamide resistance and influences
the localization of the protein. These data are consistent with the
idea that the function of Yap1p is different at promoters of loci
involved in H2O2 tolerance from promoters of
genes involved in diamide resistance.
 |
INTRODUCTION |
To grow in the presence of oxygen,
cells must be able to deal with reactive oxygen species (ROS) that are
produced during metabolism. Aerobes have the ability both to detoxify
ROS and to repair macromolecules that are damaged by these highly
reactive compounds (26). Owing to the potentially lethal
action of ROS, cells maintain constant surveillance of intracellular
ROS levels and rapidly activate the expression of loci involved in
oxidative stress tolerance (7).
The yeast Saccharomyces cerevisiae has been a useful model
for studies of the eukaryotic response to oxidant challenge
(15). S. cerevisiae produces a variety of
enzymes, such as catalase, superoxide dismutase, and glutathione
peroxidase, and small molecules and peptides (glutathione and
thioredoxins) that detoxify ROS (reviewed in reference
10). Recent data have provided insight into the
regulation of the biosynthesis of these enzymatic activities.
One of the key regulators of oxidative stress tolerance in S. cerevisiae is the Yap1p transcription factor. The YAP1
gene is required for normal tolerance to a wide variety of oxidants and
is essential for normal synthesis of a variety of antioxidant activities, including glutathione and glutathione reductase (4, 5,
19, 27). Later studies established that Yap1p-dependent transactivation was markedly enhanced when cells were challenged with
oxidants including diamide and H2O2
(13). Western blotting experiments demonstrated that
the increased activity of Yap1p was probably due to a
posttranslational modification of the factor (14, 24).
Mutational analyses have implicated a set of three cysteine residues
contained in the C-terminal cysteine-rich domain (c-CRD) of the factor
as being required for the normal elevation of Yap1p transactivation
upon oxidative stress (14, 24). Cysteine residues have been
implicated as likely sensors of the reducing environment of cells in
other redox-regulated transcription factors (reviewed in reference
22). Recent studies have implicated the c-CRD in
maintaining Yap1p in the cytoplasm until oxidant challenge drives the
protein into the nucleus (14, 29). Deletion of the c-CRD
produced a mutant Yap1p that appeared to be constitutively localized in
the nucleus and conferred a hyperresistance phenotype to diamide
(14). These data led to the model that regulation of Yap1p
by the redox state of the cell was via oxidant-regulated nuclear
localization regulated by the c-CRD of the protein (14, 29).
In this work, we demonstrate that the regulatory role of the Yap1p
c-CRD cannot be solely to modulate nuclear localization of the factor.
Loss of the c-CRD results in a Yap1p derivative that confers
hyperresistance to diamide but hypersensitivity to H2O2. This phenotypic pattern is reproduced by
a number of different mutant forms of Yap1p lacking normal c-CRD
regions. A second CRD, in the amino terminus of Yap1p (n-CRD), is
also required for normal oxidative stress regulation of the protein.
Finally, we show that while Yap1p c-CRD mutants activate the expression
of a synthetic reporter gene to high levels, these mutant derivatives
fail to normally activate the promoter of a gene required for
H2O2 tolerance. These data argue that mutants
lacking wild-type CRD regions are defective in an additional regulatory
function required for activation of transcription at promoters involved
in H2O2 resistance.
 |
MATERIALS AND METHODS |
Yeast methods.
The yeast strains used in this study were
SEY6210 (MAT
leu2-3,112 ura3-52 his3-
200 trp1-
901
lys2-801 suc2-
9 Mel
), SM12 (MAT
leu2-3,112 ura3-52 his3-
200 trp1-
901 lys2-801 suc2-
9
Mel
yap1-
1::HIS3 ARE-TRP5-lacZ), SM13
(MAT
leu2-3,112 ura3-52 his3-
200 trp1-
901 lys2-801
suc2-
9 Mel
yap1-
2::hisG), YSC6
(MAT
leu2-3,112 ura3-52 his3-
200 trp1-
901 lys2-801
suc2-
9 Mel- yap1-
2::hisG ARE-TRP5-lacZ), and
YSC18 (MAT
leu2-3,112 ura3-52 his3-
200 trp1-
901 lys2-801
suc2-
9 Mel
yap1-
2::hisG TRX2-lacZ).
YSC6 was constructed by cutting pTEP9 (ARE-TRP5-lacZ) with
KpnI (to direct recombination to LEU2) and transforming SM13 to Leu2+. YSC18 was generated by cutting
pSC99 containing TRX2-lacZ with NheI and
integrating this linear plasmid in the HIS3 gene of SM13. YSC6 and YSC18 were both checked by Southern blotting to confirm proper
chromosomal structure of the recombinants. YSC25 was constructed by
transforming SEY6210 with SacI-cleaved pGC61
(skn7
::TRP1). YSC26 (
skn7 yap1)
was produced by transforming YSC25 with a
Asp718-SacI fragment containing
yap1-
2::hisG-URA3-hisG. Ura3+
transformants were treated with 5-fluoroorotic acid to remove the
URA3 gene. Yeast cells were grown either in rich,
nonselective medium (yeast extract-peptone-dextrose medium [YPD]),
minimal medium (synthetic dextrose [SD]) with required supplements,
or SD supplemented with Casamino Acids (20). Transformation
was performed by the lithium acetate technique of Ito et al.
(9). Assays for
-galactosidase activity were carried out
on permeabilized cells as described previously (6) or with a
luminescent substrate for detection of low levels of
-galactosidase
activity as described by the manufacturer (Clontech). Diamide and
H2O2 resistance assays were carried out by spot
tests (28).
Plasmids.
The integrating ARE-TRP5-lacZ construct
pTEP9 has been described previously (25). Low-copy-number
plasmids carrying the wild-type or CSE629AAA forms of YAP1 (pSM58wt and
pSMS37, respectively) were constructed previously (24). The
YAP1 deletion mutant plasmids pJAW1 and pJAW15 were
described previously (25). All PCR products were sequenced
in their entirety to ensure that no errors had occurred during amplification.
The integrating TRX2-lacZ plasmid (pSC99) was generated by
PCR. A 505-bp fragment of the TRX2 promoter and translation
start signals was produced with an upstream primer (GCG AAT TCA TCC AGA
CTT TTA CGG GTG GCA) and a downstream primer (GCG GAT CCG TGA CCA TTA
TTG ATG TGT TA) corresponding to positions
497 to +8. The resulting
product was cleaved with EcoRI-BamHI and cloned into the lacZ fusion plasmid pSEYC102 (3) to
produce plasmid pSC99. An EcoRI-SalI
TRX2-lacZ fragment was then cloned from pSC99 into pRS303 to
form the integrating reporter plasmid.
The low-copy-number YRETRX2-CYC1-lacZ reporter
plasmid was generated in two steps. First, a CYC1-lacZ
fusion gene was isolated from pCBS1 (8) as a
SalI-NruI fragment and cloned into
SalI-SmaI-cleaved pRS314 (21). The
resulting low-copy-number TRP1 CYC1-lacZ plasmid was
designated p314ClZ. To analyze the function of the TRX2
Yap1p response elements (YREs), oligonucleotides corresponding to the YREs at position
181 were generated. The oligonucleotides had the
following sequences:
181 top, GAT CCT CTT TTC TTA CTA AGC GCG TTC;
181 bottom, GAT CGA ACG CGC TTA GTA AGA AAA GAG.
The underlined residues correspond to the TRX2 YREs. These
oligonucleotides were annealed and cloned into
BglII-digested p314ClZ.
Fusions between the TRX2 promoter region and
CYC1-lacZ were constructed by PCR. All fragments except the
255 to
141 fragment were inserted as
BamHI-BglII fragments into the BglII
site of p314CIZ. The
255 to
141 fragment was inserted as a
SalI-EcoRV fragment into
SalI-BglII-filled p314ClZ plasmid. All
PCR-generated fragments were sequenced to ensure that no errors had
occurred during amplification and cloning.
The alanine scanning mutations were generated by PCR in a two-step
procedure as described previously (18). The mutagenic primers used were as follows: C629A, ATG GCA AAG GCA AAA GCC TCA GAA
AGA GGG GTT GTC ATC AAT; S630A, ATG GCA AAG GCA AAA TGT GCG GAA AGA GGG
GTT GTC ATC AAT; and E631A, ATG GCA AAG GCA AAA TGT TCA GCA AGA GGG GTT
GTC ATC AAT. Each alanine mutant generated was cloned as an
Asp718-HindIII fragment into pSMS37. These
plasmids were then examined for the loss of a SacII
restriction site and sequenced to avoid introduction of an unwanted mutation.
Amino-terminal internal deletions were generated by PCR. All PCR
amplifications were performed with pSM58wt as a template. The
220-243 and
220-307 internal YAP1 deletions were
constructed by using custom primers (GGA GTT CGT CGA CTT AAT AAC ACA
CCA AAC TCC to synthesize the fragment starting at residue 244 and GGA ATT CGT CGA CAG GTA TGT GGA ACA AGG CAA to synthesize the fragment starting at residue 308). The standard M13 reverse-sequencing primer
was used as the reverse PCR primer. The PCR products were cloned into
pBluescript KSII+ as EcoRI fragments. These deletion fragments were then transferred back into the context of the
YAP1 gene by replacing the SalI-KpnI
fragment from the
220-335 YAP1 deletion mutant described
previously (25). The
317-335 deletion was constructed by
PCR amplification of the 5' end of the YAP1 gene with custom
forward (GGG AGA TCT CCA TGA GTG TGT CTA CCG CCA AGA GGT CGC TGG AT)
and reverse (GGA ATT CGT CGA CCA ATG GGA CAT TGC CTT GTT CC) primers.
The PCR product was inserted as a BglII-EcoRI
fragment into BamHI-EcoRI-cleaved pBluescript
KSII+. From this clone, a HpaI-SalI fragment
containing the coding sequence for residues 156 to 317 was placed into
the same sites in the
220-335 YAP1 deletion mutant to
generate the complete
317-335 YAP1 clone. The C303A
mutant was constructed by using a forward primer with a 5'
XhoI restriction site (CGC TCG AGG ATT AAG TGA CGC TAC AGA
TTC CTC CAG) and a reverse mutagenic primer with an EcoRI
restriction site (GCC GAA TTC TTC GAA GCA AAC TCC GAA ACT TG). The underlined GC identifies the mutant positions in the primer.
This PCR product was cloned as a XhoI-EcoRI
fragment into pBluescript KSII+ and then subcloned as an
Eco47III/BstBI fragment into pUC19-BH3
(25). This recombinant contained the C303A mutant in a
YAP1 BamHI-HindIII fragment, which was used
to replace the same BamHI-HindIII fragment in
pSM58wt to generate the full-length YAP1 C303A.
The wild-type green fluorescent protein (GFP)-YAP1 fusion
gene was constructed by a PCR-based method (30). Primers NT3
(AAG TTG TTT CTT AAA CCA TGT CTA AAG GTG AAG AA) and NT4
(CTC TTG GCG GTA GAC ACA CTT TTG TAC AAT TCA TC) were used
to amplify the GFP gene from an appropriate template. The
underlined segments represent YAP1 sequence flanking the ATG
and result in GFP being inserted between codons 1 and 2 of
YAP1. This YAP1-GFP chimeric fragment was then
annealed to a YAP1 plasmid and the resulting template used
in two separate PCR reactions. Additional upstream DNA flanking
YAP1 was appended to the YAP1-GFP chimera with
primers NT4 and C (GGA ACA AGA GTC CAC), while additional downstream
DNA was attached with primers NT3 and D (TGG AGG AAT CTG TAG CGT CA).
The products of each of these reactions were purified, mixed, and
subjected to a final PCR with primers C and D. This PCR product was
transformed into
yap1 cells along with a
YAP1-containing plasmid that had been gapped by restriction
enzyme cleavage. This gap removed the YAP1 promoter and
N-terminal coding sequences from residues 1 to 63. Recombinants between
the PCR product and the gapped plasmid were selected, and the structure
of the GFP-YAP1 fusion gene was verified by restriction
enzyme digestion and DNA sequence analysis. Mutant forms of this
GFP-YAP1 fusion were constructed by replacing the wild-type
BamHI-HindIII fragment with the same fragment
from a mutant construct of interest.
Construction of a YAP1 mutant library and selection
of hyperactive YAP1 alleles.
The c-CRD-encoding region
of YAP1 was subcloned as an
Asp718-HindIII fragment into pBluescript
KSII+ to form pSMS26. A 20-µg portion of this plasmid was then
mutagenized with 100 µl of 45% formic acid for 10 min. DNA was
recovered by ethanol precipitation, and the carboxy terminus of
YAP1 was amplified by PCR with flanking T3 and T7 primers.
The PCR product was cleaved with
Asp718-HindIII and ligated into the context
of wild-type YAP1. The resulting library was amplified in
bacteria, and plasmid DNA was generated.
The yeast strain SM12 was transformed with the library and replica
plated onto YPD plates containing 2.5 mM diamide. The wild-type YAP1 gene is not able to support growth at this
concentration of diamide (data not shown). Survivors were tested for
increased expression from the ARE-TRP5-lacZ reporter, and
plasmids were recovered. Recovered plasmids were retransformed into
SM12 and retested for increased diamide resistance and
ARE-TRP5-lacZ expression. The sequence of the
carboxy-terminal segment was determined by the University of Iowa DNA
Core Facility with a custom oligonucleotide primer.
Western blotting analysis.
Cells were grown in 100 ml of
minimal medium to an absorbance at 600 nm (A600)
of 0.6, drug was added, and cells were incubated for an additional
1.5 h. Diamide or hydrogen peroxide was added to give final
concentrations of 1.5 mM and 1.0 mM, respectively. Cells were
harvested, washed, and broken by glass bead lysis in buffer containing
300 mM sorbitol, 100 mM NaCl, 5 mM MgCl2, 10 mM Tris (pH
7.4), and complete protease inhibitors (Boehringer Mannheim). Cell
lysates were cleared, and the Bradford protein assay (Bio-Rad) was used
to determine the protein concentration of the supernatant. Portions (50 or 100 µg) of protein from each sample were run on an 8%
polyacrylamide gel. The proteins were transferred to nitrocellulose,
blocked with 2.5% nonfat dry milk in phosphate-buffered saline, and
probed with the anti-Yap1p polyclonal antiserum. Horseradish
peroxidase-conjugated secondary antibody and the ECL kit (Pierce) were
used to visualize immunoreactive protein. The affinity-purified Yap1p
antiserum was prepared by passing serum over columns of protein extract
prepared from a
yap1 strain or bacterially purified Yap1p
linked to Sepharose beads as specified by the manufacturer (Pierce
Amino-link).
Fluorescence microscopy analysis.
Transformants expressing
GFP-Yap1p fusions of interest were grown and subjected to oxidative
stress as described above. After the desired stress regimen had been
imposed, the cells were incubated with 4',6-diamidino-2-phenylindole
(DAPI) to visualize DNA. Cells were then viewed with an Olympus BX60
fluorescence microscope. Images were captured with a Hammamatsu ORCA
charge-coupled device camera and processed with Adobe Photoshop 5.0 software.
 |
RESULTS |
Alanine-scanning mutagenesis of the CSE629 repeat.
Previous
studies from our laboratory (24) and others (14,
29) have implicated cysteine residues in the c-CRD as being critical for the normal response of Yap1p to oxidant challenge. These cysteines in the Yap1p c-CRD are present as three CSE repeat clusters, and our data suggested that the most C-terminal of these clusters (CSE629) played a major role in regulation of Yap1p
function (24). However, these mutagenesis experiments
involved replacing all three amino acids of the CSE repeats with
alanine residues and precluded an individual assessment of the
regulatory contribution of each individual amino acid. To explore the
necessity of each position in the CSE629 repeat for normal control of
Yap1p function, each amino acid was individually replaced with an
alanine residue. The resulting single-amino-acid substitution mutants
were then assayed for their ability to transactivate a Yap1p-dependent
lacZ reporter gene, oxidative stress phenotypes, and
steady-state protein levels.
Irrespective of which of the CSE629 residues were replaced with
alanine, the resulting mutant protein behaved as a strong constitutive
activator of the ARE-TRP5-lacZ reporter gene (Fig. 1). All three of the
single-alanine-substitution mutations essentially reproduced the
constitutive hyperactive phenotype of the original CSE629AAA allele
described previously (24).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Transactivation of ARE-TRP5-lacZ expression
by alanine scanning mutations in CSE629. Strain YSC6
(yap1- 2::hisG ARE-TRP5-lacZ) was transformed
with low-copy-number plasmids expressing the indicated forms of Yap1p.
Transformants were grown on SC medium (20) to an
A600 of 0.6 and then split into three equal
aliquots, which were subjected to diamide- or
H2O2-induced oxidative stress or left untreated
(No Stress) for 1.5 h. Cells were then processed and
-galactosidase activity was measured as described previously
(6). The locations of the basic-region leucine zipper DNA
binding domain and the two separable transactivation domains in Yap1p
are indicated on the left-hand side of the figure. The drawing
represents the Yap1p protein chain, and the numbers indicate the
position along the factor.
|
|
Along with the analysis of the activation of the Yap1p-dependent
reporter gene, each mutant factor was tested for its ability to
complement the diamide- and H2O2-hypersensitive
phenotypes of a
yap1 strain. The mutant Yap1p proteins
were expressed from low-copy-number plasmids and challenged for growth
in the presence of increasing concentrations of oxidants (Fig.
2A). Each of the single-alanine-replacement mutants exhibited the same
diamide-hyperresistant and H2O2-hypersensitive
phenotypes as those conferred by the CSE629AAA triple-mutant protein.
Western blot analyses established that the three single-replacement
mutations were all expressed at levels roughly comparable to that of
the wild-type factor (Fig. 2B). These data establish that while the
cysteine residue at position 629 is necessary for appropriate redox
control of Yap1p function, it is not sufficient.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 2.
Phenotype and expression of alanine-scanning mutations
in CSE629. (A) Cells lacking the YAP1 gene
( yap1) were transformed with low-copy-number plasmids
expressing the indicated forms of Yap1p or the vector only (pRS316).
Transformants were grown to an A600 of 1, and
spots of 1,000 cells were placed on YPD containing diamide or
H2O2. Each oxidant was present in a
concentration gradient, as indicated by the bar at the top of the
figure. (B) yap1 cells expressing the indicated forms of
Yap1p were grown in the absence of oxidants (U) or challenged for 1.5 h
with diamide (D) or H2O2 (H). Protein extracts
were prepared, and either 50 µg (wild-type Yap1p) or 100 µg
(mutants) of protein was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. The gel was then
transferred to nitrocellulose and probed with a rabbit anti-Yap1p
antiserum (24). Bound antibody was detected by using goat
anti-rabbit antibody and chemiluminescence (Pierce).
|
|
Random mutagenesis of the Yap1p C terminus.
To gain additional
insight into the amino acids required for normal function of the Yap1p
C terminus, we generated a collection of random mutations in a
restriction fragment encoding this region of the factor (see Materials
and Methods for details). This restriction fragment was then
reintroduced into an otherwise unaltered YAP1 gene carried
on a low-copy-number plasmid. This mutant plasmid pool was transformed
into a
yap1 strain carrying the ARE-TRP5-lacZ gene, and transformants that were hyperresistant to diamide were selected. Cells that exhibited enhanced diamide tolerance were then
assayed for their levels of ARE-directed
-galactosidase activity.
Plasmids were recovered from colonies that expressed elevated
-galactosidase levels and tested for their ability to retransform
both the diamide hyperresistance and the high-level ARE-TRP5-lacZ expression on a fresh version of the original
yap1 strain. Plasmids that were able to retransform these
traits were then subjected to DNA sequence analysis to identify the
altered position in the C terminus.
While a large number of mutant plasmids were recovered, we focused our
attention on four different mutations, since these served to define the
general classes of lesions that would give rise to a hyperactive form
of Yap1p. To designate the identity of the mutation recovered, the
wild-type residue is listed in the single-letter code followed by the
position and finally the residue present in the mutant. The nonsense
terminations are designated X in the mutant residue position.
We recovered two distinctly different mutant classes of hyperactive
Yap1p: nonsense mutations K626X and C598X and missense mutations V616D
and C620F. All four of these mutant alleles led to high-level
constitutive expression of the Yap1p-dependent reporter gene and
markedly increased diamide resistance above that conferred by the
wild-type protein (Fig. 3 and
4). Interestingly, these C-terminal
mutant proteins failed to restore normal levels of H2O2 resistance to the
yap1
strain. All these mutant proteins were detectable by Western blot
analysis under control and oxidative stress conditions, indicating that
their in vivo behavior could not be explained by a change in
expression of the mutant factors relative to the wild-type
protein. These data strongly support the idea that the function of the
c-CRD of Yap1p varies depending on the oxidative challenge the cell is
experiencing.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
ARE-TRP5-lacZ expression supported by
diamide-hyperresistant mutants with mutations in the c-CRD region. (A)
The sequence of the C-terminal 53 amino acids of Yap1p is shown in the
single-letter amino acid code. The numbers refer to the position of
each amino acid along the 650-residue length of Yap1p, and the
locations of the three CSE repeats are indicated by underlining. The
highlighted region corresponds to a putative nuclear export signal as
suggested previously (29). The position and sequence of each
mutant analyzed here are indicated above the amino acid sequence. (B)
The ability of each mutant to regulate gene expression was assayed by
introducing low-copy-number plasmids expressing the indicated forms of
Yap1p into a yap1 strain containing the
ARE-TRP5-lacZ reporter gene, as described for Fig. 1. Levels
of ARE-dependent -galactosidase activity were determined in the
unstressed cells (No Stress) and in cells subjected to diamide- or
H2O2-induced oxidative stress.
|
|

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 4.
Oxidative stress phenotypes and expression level of
random mutants with mutations in the c-CRD. (A) yap1
cells were transformed with low-copy-number plasmids expressing the
indicated forms of Yap1p. Transformants were assayed for their ability
to tolerate diamide- or H2O2-induced stress by
a spot test assay as described in the legend to Fig. 2. (B)
Steady-state protein levels of the indicated Yap1p derivatives were
determined by Western blotting with the rabbit anti-Yap1p antiserum as
described in the legend to Fig. 2.
|
|
An N-terminal cysteine-rich domain regulates Yap1p function.
Analysis of an internal-deletion derivative of Yap1p that lacked
residues 220 to 335 (Yap1p
220-335) indicated that this segment of
the protein was required for normal regulation (24, 25).
Loss of the region from residues 220 to 335 resulted in a Yap1p
derivative that conferred hyperresistance to diamide but failed to
provide normal H2O2 resistance. A striking
feature of the region of Yap1p from residues 220 to 335 was the
presence of the only other three cysteine residues in the protein.
Since the cysteine residues in the c-CRD play important roles in
regulation of Yap1p, we prepared a series of mutations to examine in
more detail the possible role of these N-terminal cysteines in control of Yap1p function. Each mutant factor was expressed from a
low-copy-number plasmid and assayed for the ability to complement both
the ARE-TRP5-lacZ expression levels and oxidative stress
phenotypes of a
yap1 strain (Fig.
5 and 6).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
The n-CRD is required for normal redox regulation. The
extent of the Yap1p sequence deleted in each construct is indicated by
the gap and by the numbers on the left-hand side of the drawing. The
other symbols and labeling are as in Fig. 1. ARE-dependent
-galactosidase activity was determined for each construct as
described in the legend to Fig. 1.
|
|

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 6.
Oxidant resistance and expression profiles of n-CRD
mutant proteins. yap1 cells were transformed with
low-copy-number plasmids expressing the indicated forms of Yap1p.
Oxidative stress phenotypes (A) and steady-state protein levels (B)
were assayed as described in the legend to Fig. 2.
|
|
Three different deletion derivatives were prepared to explore the role
of the three cysteine residues at positions 303, 310, and 315, respectively. A small truncation that removed residues 220 to 243 (Yap1p
220-243) while maintaining all the cysteines in the N
terminus was generated. Yap1p
220-243 was strongly derepressed under nonstressed conditions and produced 52 U per optical density unit
(A600) of
-galactosidase activity compared to
only 7 U/A600 for the wild-type protein (Fig.
5). Yap1p
220-243 was still able to confer oxidant-inducible
expression on the ARE-TRP5-lacZ fusion, albeit to a lesser
extent than was the normal factor. The oxidant resistance profile (Fig.
6) of Yap1p
220-243 correlated well with the expression of the
ARE reporter gene, with this mutant factor conferring
hyperresistance to diamide and even modestly increasing tolerance to
H2O2. These data supported the idea that the
region of Yap1p from residues 220 to 243 normally acted to repress the
activity of the protein.
Further deletion to position 307 generated a mutant regulatory protein
(Yap1p
220-307) that lacked the most N-terminal of the six cysteine
residues normally contained in this factor. This mutant factor behaved
nearly indistinguishably from Yap1p
220-335, conferring increased
diamide-dependent reporter gene expression and diamide tolerance, along
with decreased expression in response to H2O2
and depressed tolerance of this oxidant. Finally, a truncation mutant
that lacked sequences immediately downstream from the three N-terminal
cysteine residues was analyzed. This mutant (Yap1p
317-335) behaved
normally under both nonstressed and diamide-challenged conditions but
failed to respond to H2O2 stress, even though
all three amino-terminal cysteine residues were still present.
Together, these data argue that this n-CRD is required for normal
regulation of Yap1p by oxidative stress even if the c-CRD is fully intact.
Since each of the above-described deletion mutants lacked sequences
around the cysteine residues of the n-CRD, we were unable to confirm if
these particular amino acids were key players in the function of this
N-terminal regulatory region. A site-directed mutation changing
cysteine 303 to an alanine was prepared to examine the role played by
this amino acid in the response of Yap1p to oxidant challenge. As with
the deletion mutations, this substitution mutation was expressed from a
low-copy-number plasmid and subjected to the same battery of
assays for Yap1p function. Yap1p C303A behaved like the wild-type
factor in the absence of stress and upon diamide stress. However, Yap1p
C303A was unable to respond to H2O2 challenge,
as assayed by either ARE-TRP5-lacZ expression or
complementation of H2O2 sensitivity of
yap1.
Genetic interaction of two negative regulatory domains in
Yap1p.
The above data strongly suggested that both the n-CRD and
c-CRD are crucial for the normal response to oxidants. To evaluate if
these two spatially separate regulatory domains control Yap1p activity
through a common regulatory step, we constructed a double-mutant factor
lacking the region from residues 220 to 335 and carrying the CSE629AAA
allele. This double-mutant factor (Yap1p
220-335/CSE629AAA) was introduced into
yap1 strains carrying the
ARE-TRP5-lacZ reporter gene. Plasmids expressing the
220-335 or CSE629AAA forms of Yap1p alone were assayed as controls.
Yap1p
220-335/CSE629AAA behaved as a factor exhibiting the sum of
the characteristics of each of the single mutants (Fig. 7). This double-mutant protein led to
three important changes in the properties of Yap1p compared to the
single Yap1p CSE629AAA derivative. First, the Yap1p
220-335/CSE629AAA exhibited increased basal
-galactosidase
activity from the ARE-TRP5-lacZ. Second, the double mutant
led to increased resistance to diamide. Third, the Yap1p
220-335/CSE629AAA protein accumulated to much higher levels than
did the original Yap1p CSE629AAA mutant. Taken together, these data
argue that Yap1p receives regulatory information through both its N-
and C-terminal regions.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 7.
The n- and c-CRD regions contribute regulatory
information to the redox response of Yap1p. (A) All Yap1p derivatives
were introduced on low-copy-number plasmids into the yap1
ARE-TRP5-lacZ reporter strain and assayed for ARE-dependent
-galactosidase activity as described in the legend to Fig. 1. (B)
Oxidative stress resistance phenotypes of yap1 cells
carrying low-copy-number plasmids expressing the indicated forms of
Yap1p were assayed as described in the legend to Fig. 2. (C)
Steady-state protein levels of the double and single CRD mutants were
analyzed by Western blotting. This blot was probed with
affinity-purified anti-Yap1p antiserum that was depleted for antibodies
that recognize the nonspecific protein species. The double CRD mutant
was grown in the absence of stress (U) or subjected to oxidative stress
by exposure to diamide (D) or H2O2 (H) prior to
preparation of protein extracts.
|
|
Trafficking information for Yap1p is contained in both the n- and
c-CRD regions.
Previous studies have demonstrated that Yap1p
subcellular localization changes from primarily cytoplasmic in the
absence of stress to nuclear when cells are challenged with either
diamide or diethylmaleate (14). We wanted to examine the
localization of Yap1p in response to mutations in the n-CRD and
H2O2 challenge, two issues that have not been
previously explored. To facilitate evaluation of the Yap1p subcellular
location, we used PCR to insert the GFP after the ATG codon of the
wild-type YAP1 gene. The resulting GFP-Yap1p chimera was
carried on a low-copy-number plasmid. Mutant coding sequences were
introduced into this fusion gene in vitro and then transformed into a
yap1 strain carrying the ARE-TRP5-lacZ reporter gene.
Transformants were assayed for their oxidative stress resistance
phenotypes, regulation of the ARE-TRP5-lacZ gene, and
steady-state protein levels to ensure that the addition of the GFP
moiety to the amino terminus did not alter the behavior of either the
wild-type or mutant Yap1p derivatives that we constructed. This
analysis indicated that the presence of the 30-kDa GFP domain on the
amino terminus of these Yap1p derivatives did not alter their
previously analyzed behavior (data not shown). We next assessed the
subcellular distribution of the wild-type and mutant forms of Yap1p by
fluorescence microscopy (Fig. 8).

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 8.
Oxidant-specific subcellular localization of Yap1p.
Low-copy-number plasmids expressing the indicated alleles of
YAP1 as GFP fusion proteins were introduced into
yap1 cells. Transformants were grown under nonstressed
conditions (Uninduced) or subjected to oxidative stress elicited by
diamide or H2O2. Living cells were then stained
with DAPI and analyzed by microscopy for Yap1p localization (GFP) and
DAPI fluorescence.
|
|
Wild-type Yap1p is not found in the nucleus in the absence of stress
but is clearly localized in this organelle in response to diamide
challenge, as seen previously (14, 29). Importantly, H2O2-elicited oxidative stress also caused
Yap1p to localize to the nucleus. Irrespective of the agent used to
elicit oxidative stress, the subcellular localization of Yap1p changes
in response to this stress. Yap1p V616D is constitutively localized in
the nucleus, independent of diamide- or
H2O2-induced oxidative stress. These data
indicated that the failure of Yap1p V616D to normally complement the
H2O2-hypersensitive defect of a
yap1 strain is not due to a failure to localize to the
nucleus when cells are treated with this oxidant. Localization of Yap1p
C620F was indistinguishable from that of the V616D derivative (data not shown).
Along with these two c-CRD mutant proteins, subcellular localization of
four different n-CRD mutant derivatives was examined. Yap1p
220-335
was previously found to be inducible by diamide- but not
H2O2-elicited oxidative stress (24).
One possible explanation for this behavior is the failure of this
mutant protein to translocate to the nucleus in response to
H2O2 treatment. Analysis of the ability of
diamide and H2O2 to induce nuclear accumulation
of the Yap1p
220-335 mutant showed that this mutant protein entered the nucleus under both conditions, indicating that the
H2O2 defect of this factor was not due to
defective trafficking. Two smaller n-CRD mutants (Yap1p
220-243 and
220-307) were also examined for their subcellular
distribution. Yap1p
220-243 produced 700% more expression of
the ARE-TRP5-lacZ relative to the wild-type Yap1p in the
absence of oxidative stress (Fig. 5) and was constitutively localized
in the nucleus, consistent with the high, oxidant-independent level of
gene expression support by this mutant protein. A larger n-CRD deletion
derivative lacking sequences from positions 220 to 307 was also
constitutively localized to the nucleus but otherwise behaved similarly
to the Yap1p
220-335 mutant. Note that even though the c-CRD was
unaltered in both Yap1p
220-243 and Yap1p
220-307, these mutant
factors were still present in the nucleus in the absence of oxidative stress.
Since these deletion derivatives might have a grossly disturbed protein
structure that precludes normal functioning of the c-CRD, we assayed
the subcellular localization of a single-amino-acid replacement form of
Yap1p (Yap1p C303A) that changed a cysteine residue in the n-CRD to
alanine. This mutant derivative was also constitutively localized in
the nucleus in an oxidant-independent fashion. Yap1p
220-243, Yap1p
220-307, and Yap1p C303A have wild-type c-CRD regions but still
exhibit constitutive nuclear localization. These data indicate that the
n-CRD also contains targeting information that is required for normal
functioning of Yap1p.
Differential activation of a TRX2-lacZ reporter gene in
response to oxidant exposure.
One complicating feature of the
behavior of several mutant Yap1p derivatives characterized in this work
and previously (24) was the ability of some mutants (such as
Yap1p K626X [Fig. 4]) to strongly activate ARE-TRP5-lacZ
expression in the presence of H2O2 but their
inability to confer even normal H2O2 resistance on a
yap1 strain. One hypothesis to explain this
discrepancy was that a unique action of the Yap1p C terminus was
required at promoters involved in H2O2
tolerance but not at promoters of genes playing a role in diamide
resistance. To directly test this idea, we analyzed the ability of
several different mutant derivatives of Yap1p to stimulate the
expression of a gene involved in H2O2 resistance, TRX2.
TRX2 has previously been shown to be regulated by Yap1p and
to be required for resistance to H2O2 but not
to diamide (13). A TRX2-lacZ fusion gene was
constructed and integrated into the genome of a
yap1
strain to produce the reporter strain YSC18. This TRX2-lacZ
yap1 strain was then transformed with plasmids expressing
different forms of Yap1p, and levels of TRX2-dependent
-galactosidase in the presence or absence of oxidative stress were
determined (Table 1).
In the presence of a low-copy-number plasmid expressing wild-type
Yap1p, TRX2-dependent expression changed from 6 U/A600 under nonstressed conditions to
approximately 31 U/A600 when challenged with
either diamide or H2O2. Overproduction of Yap1p
from a 2µm plasmid led to high-level expression of TRX2,
which was no longer responsive to oxidative stress. In the absence of
an intact YAP1 structural gene, the TRX2 reporter
gene produced low-level enzyme activity, which was not inducible by
oxidative stress. These data are consistent with those reported
previously (13, 16) and establish that this
TRX2-lacZ gene faithfully reflected Yap1p regulation of the
endogenous gene.
The expression of the TRX2-lacZ gene was then examined in
the presence of an array of different mutant derivatives of Yap1p. Yap1p CSE629AAA was found to be a strong constitutive activator of
ARE-TRP5-lacZ expression when challenged with either diamide or H2O2, but although this mutant protein
conferred hyperresistance to diamide, it did not normally complement
H2O2 tolerance in a
yap1
background (24). In the absence of oxidative stress,
TRX2-lacZ expression in the presence of the Yap1p CSE629AAA
allele was elevated to 13 U/A600
compared to 6 U/A600 in the presence of the
wild-type protein. However, Yap1p CSE629AAA was able to increase
TRX2-lacZ expression to only 21 U/A600 when exposed to diamide and, importantly, completely failed to respond to H2O2 challenge.
Two other C-terminal mutants (the C629A and V616D mutants) exhibited
the same inability to increase TRX2-lacZ expression after
H2O2 exposure, even though each of these mutant
factors was able to confer diamide hyperresistance and high-level
expression of the ARE-TRP5-lacZ fusion gene.
Along with these C-terminal mutant proteins, several N-terminal mutants
were tested for their ability to elevate TRX2-lacZ expression during H2O2-induced oxidative
stress. Yap1p
220-243 normally conferred
H2O2 resistance and strongly induced the
expression of the TRX2 reporter gene in the presence of
H2O2. Two other N-terminal mutant proteins
(Yap1p
220-335 and Yap1p C303A) that both failed to normally
complement the H2O2-hypersensitive defect of
the
yap1 strain were also incapable of stimulating
TRX2-lacZ expression. These data strongly support the idea
that the function of Yap1p in response to oxidative stress elicited by
H2O2 is not the same as that during diamide stress.
The TRX2 YRE is capable of responding to Yap1p
C629A.
To examine if the failure of a c-CRD mutant form of Yap1p
to elicit overproduction of TRX2 was due to some property of
the YRE in TRX2, we examined the ability of a YRE in the
TRX2 promoter to serve as a Yap1p-dependent upstream
activator sequence of a heterologous promoter. An oligonucleotide
that corresponds to the TRX2 YRE at position
181 in the
promoter of this gene was synthesized. This oligonucleotide
(YRETRX2) was placed upstream of a
CYC1-lacZ promoter in place of the normal CYC1
upstream activator sequence elements. The resulting construct was then introduced into
yap1 cells along with a low-copy-number
plasmid expressing either the wild-type or C629A forms of Yap1p. The
vector plasmid alone was included as a control. Transformants were
grown in selective media and YRETRX2-dependent
-galactosidase activity determined as described above.
Expression of the YRETRX2-CYC1-lacZ fusion gene
was constitutively high in the presence of the Yap1p C629A mutant (Fig.
9). Significantly, in the absence of
stress, the expression level of the
YRETRX2-CYC1-lacZ reporter gene was
approximately 300% greater when the C629A form of Yap1p was present
than when the wild-type factor was present. When the
TRX2-lacZ was used as the reporter gene in this same
comparison (Table 1), only a 50% increase in expression was seen when
the C629A and wild-type forms of Yap1p were compared. This experiment
suggests that the behavior of this TRX2 YRE is modified by
the normal TRX2 promoter context in which it is embedded.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 9.
A TRX2 YRE is capable of responding to Yap1p
C629A when assayed in a heterologous promoter context. An
oligonucleotide corresponding to the YRE present at position 181 in
the TRX2 promoter (YRETRX2) was
inserted into a CYC1-lacZ fusion plasmid in place of the
normal CYC1 upstream sequences. This
YRETRX2-CYC1-lacZ fusion gene was carried on a
low-copy-number plasmid and introduced into a yap1 strain
along with a second low-copy-number plasmid containing the indicated
forms of Yap1p. Transformants were grown and assayed for
-galactosidase activity by using a chemiluminescent substrate as
described in Materials and Methods.
|
|
The
141 to
61 region of the TRX2 promoter blocks
H2O2 induction in the absence of a normal c-CRD
region of Yap1p.
To map the region of the TRX2 promoter
that requires the function of the Yap1p c-CRD for induction, we fused
various segments of the 5'-flanking DNA of TRX2 to a
CYC1-lacZ fusion gene lacking its normal upstream activator
sequences. These TRX2-CYC1-lacZ fusion genes were introduced
into a
yap1 strain along with a low-copy-number plasmid
vector expressing wild-type or C629A mutant forms of Yap1p.
-Galactosidase activities under unstressed and H2O2-challenged conditions were then determined
(Fig. 10).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 10.
An intact Yap1p c-CRD region is required for normal
induction of the TRX2 promoter during
H2O2 challenge. Cells lacking the YAP1
structural gene were transformed with a low-copy-number plasmid vector
( yap1) or the same vector expressing the wild-type or C629A form of
Yap1p. Along with these three alleles of YAP1, various
fusion genes carrying the indicated segments of the TRX2
promoter region placed upstream of a CYC1-lacZ fusion gene
were introduced. The numbers are relative to the start of the
TRX2 coding sequence. The solid vertical bars indicate the
positions of the two YREs, and the single open box denotes the location
of the Skn7p binding site. -Galactosidase activities were determined
by using a chemiluminescent substrate as above.
|
|
Fusion genes containing TRX2 upstream DNA from either
500
to
61 or
255 to
61 exhibited very similar behavior. Both these reporter plasmids supported strong H2O2
induction in the presence of wild-type YAP1 but were not
induced when the C629A form of Yap1p was expressed. Both of these
chimeric TRX2-CYC1-lacZ fusion genes exhibited the same
dependence of H2O2 induction on the intact Yap1p c-CRD as was seen for the wild-type TRX2 gene. Two
further deletion derivatives that contained TRX2 promoter
DNA from
500 to
155 or
255 to
155 were constructed. These two
constructs were now able to respond to the presence of the C629A
derivative of Yap1p. Even in the absence of
H2O2 exposure, the mutant
TRX2-CYC1-lacZ fusion genes lacking the
155 to
61 region
of TRX2 produced high levels of
-galactosidase activity,
suggesting that this portion of TRX2 was responsible for the unique
requirement of this gene for the Yap1p c-CRD.
Previous work on the TRX2 promoter demonstrated that a
binding site for the transcription factor Skn7p was located between positions
164 and
142 (16). To determine if interaction
between Yap1p and Skn7p was involved in the dependence of
TRX2 H2O2 activation on the Yap1p
c-CRD, two additional experiments were performed. First, a
TRX2-CYC1-lacZ fusion gene that contained the Skn7p binding site and extended from
255 to
141 was constructed. Second, a
skn7 yap1 strain was prepared and transformed with a
plasmid expressing wild-type or C629A Yap1p or the empty vector. These transformants were then tested for expression of a TRX2-lacZ
reporter gene and H2O2 tolerance.
Inclusion of the Skn7p binding site in the
255 to
141
TRX2-CYC1-lacZ reporter plasmid did not interfere with the
ability of the TRX2 promoter segment to support high-level
expression in the presence of the C629A form of Yap1p (Fig.
11). This behavior was also seen in the
context of the wild-type TRX2 promoter (Table 1).
Irrespective of the presence of SKN7, C629A Yap1p was not able to induce TRX2 expression upon
H2O2 exposure. Consistent with the results of
others (16), loss of either YAP1 or
SKN7 blocked the ability of the TRX2-lacZ gene to
be induced by H2O2. Phenotypic assays of these
strains on H2O2 gradient plates mirrored this
defect in H2O2 activation of
TRX2 gene expression. Interestingly, Yap1p C629A was able to
slightly increase the H2O2 tolerance of a
yap1 cell but only to a fraction of the resistance shown
by a wild-type strain. We conclude from these data that the failure of
TRX2 to respond to Yap1p C629A is not dependent on Skn7p and can be rescued by removal of the DNA region between positions
141 and
61.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 11.
A hyperactive YAP1 allele cannot bypass the
Skn7p requirement of H2O2 activation of the
TRX2 promoter. A low-copy-number plasmid expressing the
indicated forms of YAP1 was introduced into yap1
skn7 or yap1 cells along with a TRX2-lacZ
gene fusion. TRX2-dependent -galactosidase activity was
determined under nonstressed (No Stress) or
H2O2-challenged conditions. (B) Aliquots of
1,000 cells of each of the transformants described in panel A were
placed on YPD containing a gradient of H2O2
increasing from left to right.
|
|
 |
DISCUSSION |
Control of the activity of the positive transcriptional regulatory
protein Yap1p is one of the key steps modulating the response of
S. cerevisiae to oxidative stress. While the action of Yap1p as a positive regulator of gene expression is required for normal tolerance to the oxidants diamide and H2O2, the
responses of Yap1p to these oxidants exhibit important differences.
These differential responses are most clearly seen in the analysis of
mutant forms of Yap1p. A number of lesions that either perturb (C629A)
or remove (K626X) the c-CRD in Yap1p produce derivatives that confer
hyperresistance to diamide yet fail to provide normal
H2O2 tolerance to a
yap1 strain.
These findings strongly suggest that the role of the Yap1p c-CRD is
different in the face of the distinct oxidative challenge elicited by
either diamide or H2O2. Diamide is believed to
shift the pool of glutathione into a predominantly oxidized state
(12), while H2O2 is a promiscuous
oxidizing agent that acts to damage many different macromolecules in
the cell (2). Since the modes of oxidative damage induced by
these two agents are not identical, the cellular responses to these
stresses are likely to be different. At least part of this selective
cellular response to these oxidants is programmed into the
oxidant-specific behavior of Yap1p.
The oxidant-specific behavior of the Yap1p c-CRD has important
implications for the physiological action of this domain of the
protein. Previous work has shown that the c-CRD is involved in the
control of Yap1p nuclear localization (14), probably at the
level of nuclear export (29). These studies led to the proposal that the Yap1p c-CRD acted to enhance nuclear export in the
absence of oxidants but that Yap1p would accumulate in the nucleus upon
oxidant challenge (14, 29). Our findings indicate that while
c-CRD-regulated localization of Yap1p may be a role of this domain of
the factor, it clearly is not the sole activity of this region.
In addition to the already recognized role of the c-CRD in regulation
of Yap1p activity, we provide evidence that the amino terminus of Yap1p
is also required for the appropriate redox response of the factor.
Importantly, the n-CRD also contains information that is required for
normal trafficking of Yap1p. Loss of small segments of Yap1p (residues
220 to 243 or 220 to 307) or a single-amino-acid substitution in the
n-CRD leads to constitutive nuclear localization of the resulting
mutant protein. However, a larger deletion mutant (Yap1p
220-335)
is normally excluded from the nucleus in the absence of oxidative
challenge. These data suggest that the n-CRD contains nuclear targeting
information that is normally masked in the absence of oxidative stress.
Loss of the sequences between positions 220 and 243 or the C303A
mutation unmasks this targeting determinant, and the mutant proteins
are found in the nucleus. A larger deletion mutant lacking residues 220 to 335 is found in the nucleus only upon oxidant challenge. This
derivative (Yap1p
220-335) may lack the targeting information that
was unmasked by the two more amino-terminal mutations.
Along with this newly identified role in redox-dependent trafficking of
Yap1p, the n-CRD is a key contributor to the ability of the protein to
activate transcription of a subset of downstream target genes. A
wild-type n-CRD is essential for normal H2O2
tolerance but dispensable for diamide resistance. This finding suggests that genes involved in H2O2 resistance require
both CRD regions to be normally activated by Yap1p but that genes
required for diamide resistance do not. Previous mutagenesis
experiments have identified other substitution mutations in both CRD
regions that confer an H2O2 sensitive phenotype
on cells and prevent normal activation of TRX2 expression
upon H2O2 challenge (23).
Interestingly, loss of the n-CRD leads to a
H2O2-specific defect in the ability of the
resulting mutant Yap1p to activate both the ARE-TRP5-lacZ and the TRX2-lacZ reporter genes whereas c-CRD mutations
prevent induction only of TRX2 transcription in the presence
of H2O2. These data suggest that Yap1p-mediated
transactivation requires normal n-CRD function at all promoters but
that c-CRD function is specifically needed to induce expression of
genes involved in H2O2 tolerance.
To determine the possible regulatory relationship of these two domains
of Yap1p, we constructed a mutant derivative that lacked both the n-CRD
(Yap1p
220-335) and c-CRD (Yap1p CSE629AAA). This was done to
determine if the n-CRD could still influence Yap1p function in the
absence of c-CRD function. One possible model explaining the roles of
the two CRD regions would be that the n-CRD acts simply to modulate
c-CRD function. In the absence of a functional c-CRD, n-CRD mutations
would not be expected to influence function of the resulting Yap1p
derivative. Contrary to this prediction, our results suggest that both
CRD regions play critical roles in Yap1p function and regulation. The
mutant lacking both the n-CRD and c-CRD regions (Yap1p
220-335/CSE629AAA) is more active than either single mutant. Both
of the CRD regions act to repress the factor during conditions of
diamide stress, and both are required for Yap1p to normally mediate
resistance to H2O2 stress.
The analysis of the c-CRD was complicated by the observation that most
c-CRD mutants behaved as constitutive activators of the
ARE-TRP5-lacZ reporter gene but failed to normally
complement the H2O2 hypersensitivity of the
yap1 mutant. Our finding that the same c-CRD mutants that
drive greater expression of the ARE-TRP5-lacZ reporter than
wild-type Yap1p fail to properly regulate transcription of the
TRX2 gene clarifies this apparent paradox. The
ARE-TRP5-lacZ reporter serves as a model promoter for the
response of isolated YREs to Yap1p. This synthetic promoter accurately
predicts the diamide resistance phenotype of all Yap1p mutant
derivatives that we have analyzed. Yap1p mutants that drive
high-level expression of ARE-TRP5-lacZ also confer a
strong diamide resistance phenotype on
yap1 cells.
However, this artificial reporter fails to predict the corresponding
H2O2 resistance phenotype of the same mutants. When c-CRD mutants are analyzed for their ability to induce
transcription of TRX2 in response to
H2O2, a marked defect is observed (Table 1).
We believe that these observations suggest that the mode of
transactivation of Yap1p at promoters involved in diamide tolerance is
different from that at promoters involved in
H2O2 resistance. Transcriptional activation of
genes involved in diamide tolerance seems to be able to be reduced to
the behavior of an isolated YRE. Up-regulation of genes required for
H2O2 resistance is more complex and must be
examined in the context of the native promoter. This is illustrated by
the analysis of the H2O2 induction of the TRX2 promoter by Yap1p. A mutant Yap1p lacking an intact
c-CRD region cannot induce TRX2 in the presence of
H2O2 unless a region of the TRX2
promoter is removed. The presence of this inhibitory region of
TRX2 also prevents the otherwise hyperactive C629A form of
Yap1p from driving high-level constitutive expression of
TRX2. These data suggest the presence of a binding site for
a factor that interacts with the Yap1p c-CRD before activation of
TRX2 can occur. This behavior is a unique feature of
TRX2, since other Yap1p target genes exhibit dramatic
increases in expression if the c-CRD is defective (1, 23).
Current work focuses on identification of the factor binding this
TRX2 inhibitory site.
Finally, it is important to contrast the physiological significance of
tolerance to either diamide or H2O2. While both
of these oxidants are useful tools to elicit oxidative stress in the
laboratory, H2O2 is arguably the more relevant
phenotype to S. cerevisiae cells in particular and
fungi in general. Neutrophils, a major host defense against fungal
infections, eliminate invading fungal cells through oxidative killing
(reviewed in reference 17). While there are several
different redox-active chemicals that can be produced by neutrophils, a
major oxidant is H2O2 (11). Understanding how fungal cells tolerate H2O2
toxicity will have important implications in the treatment of
pathogenic fungal infections.
 |
ACKNOWLEDGMENTS |
This work was supported in part by NIH grants GM49825 to W.S.M.
and DK25295 to the University of Iowa Diabetes and Endocrinology Center. W.S.M. is an Established Investigator of the American Heart
Association. Sean Coleman was the recipient of an NIH predoctoral fellowship (NIH/NIA T32 AG00214).
We thank Chris Grant for helpful discussions and Laura Davis for
sharing data prior to publication.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Physiology and Biophysics, University of Iowa, Iowa City, IA 52242. Phone: (319)-335-7874. Fax: (319)-335-7330. E-mail:
moyerowl{at}blue.weeg.uiowa.edu.
Present address: Department of Biochemistry, Health Sciences
Center, University of Virginia, Charlottesville, VA 22908.
 |
REFERENCES |
| 1.
|
Coleman, S. T.,
E. Tseng, and W. S. Moye-Rowley.
1997.
Saccharomyces cerevisiae basic region-leucine zipper protein regulatory networks converge at the ATR1 structural gene.
J. Biol. Chem.
272:23224-23230[Abstract/Free Full Text].
|
| 2.
|
Collinson, L. P., and I. W. Dawes.
1992.
Inducibility of the response of yeast cells to peroxide stress.
J. Gen. Microbiol.
138:329-335[Medline].
|
| 3.
|
Emr, S. D.,
A. Vassarotti,
J. Garret,
B. C. Geller,
M. Takeda, and M. G. Douglas.
1986.
The amino terminus of the yeast F1-ATPase beta-subunit precursor functions as a mitochondrial import signal.
J. Cell Biol.
102:523-533[Abstract/Free Full Text].
|
| 4.
|
Grant, C. M.,
L. P. Collinson,
J.-H. Roe, and I. W. Dawes.
1996.
Yeast glutathione reductase is required for protection against oxidative stress and is a target gene for yAP-1 transcriptional regulation.
Mol. Microbiol.
21:739-746[Medline].
|
| 5.
|
Grant, C. M.,
F. H. MacIver, and I. W. Dawes.
1996.
Glutathione is an essential metabolite required for resistance to oxidative stress in the yeast Saccharomyces cerevisiae.
Curr. Genet.
29:511-515[Medline].
|
| 6.
|
Guarente, L.
1983.
Yeast promoter and lacZ fusions designed to study expression of cloned genes in yeast.
Methods Enzymol.
101:181-191[Medline].
|
| 7.
|
Harris, E. D.
1992.
Regulation of antioxidant enzymes.
FASEB J.
6:2675-2683[Abstract].
|
| 8.
|
Harshman, K. D.,
W. S. Moye-Rowley, and C. S. Parker.
1988.
Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4.
Cell
53:321-330[Medline].
|
| 9.
|
Ito, H.,
Y. Fukuda,
K. Murata, and A. Kimura.
1983.
Transformation of intact yeast cells treated with alkali cations.
J. Bacteriol.
153:163-168[Abstract/Free Full Text].
|
| 10.
|
Jamieson, D. J.
1998.
Oxidative stress responses of the yeast Saccharomyces cerevisiae.
Yeast
14:1511-1527[Medline].
|
| 11.
|
Klebanoff, S. J.
1980.
Oxygen metabolism and the toxic properties of phagocytes.
Ann. Intern. Med.
93:480-489.
|
| 12.
|
Kosower, N. S., and E. M. Kosower.
1987.
Formation of disulfides with diamide.
Methods Enzymol.
143:264-270[Medline].
|
| 13.
|
Kuge, S., and N. Jones.
1994.
YAP1-dependent activation of TRX2 is essential for the response of S. cerevisiae to oxidative stress by hydroperoxides.
EMBO J.
13:655-664[Medline].
|
| 14.
|
Kuge, S.,
N. Jones, and A. Nomoto.
1997.
Regulation of yAP-1 nuclear localization in response to oxidative stress.
EMBO J.
16:1710-1720[Medline].
|
| 15.
|
Moradas-Ferreira, P.,
V. Costa,
P. Piper, and W. Mager.
1996.
The molecular defenses against reactive oxygen species in yeast.
Mol. Microbiol.
19:651-658[Medline].
|
| 16.
|
Morgan, B. A.,
G. R. Banks,
W. M. Toone,
D. Raitt,
S. Kuge, and L. H. Johnston.
1997.
The Skn7 response regulator controls gene expression in the oxidative stress response of the budding yeast Saccharomyces cerevisiae.
EMBO J.
16:1035-1044[Medline].
|
| 17.
|
Murphy, J. W.,
H. Friedman, and M. Bendinelli.
1993.
Fungal infections and immune responses.
Plenum Press, New York, N.Y
|
| 18.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
|
| 19.
|
Schnell, N.,
B. Krems, and K.-D. Entian.
1992.
The PAR1 (YAP1/SNQ3) gene of Saccharomyces cerevisiae, a c-jun homolog, is involved in oxygen metabolism.
Curr. Genet.
21:269-273[Medline].
|
| 20.
|
Sherman, F.,
G. Fink, and J. Hicks.
1979.
Methods in yeast genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
|
| 21.
|
Sikorski, R. S., and P. Hieter.
1989.
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics
122:19-27[Abstract/Free Full Text].
|
| 22.
|
Sun, Y., and L. W. Oberly.
1996.
Redox regulation of transcriptional activators.
Free Radic. Biol. Med.
21:335-348[Medline].
|
| 23.
|
Takeuchi, T.,
K. Miyahara,
D. Hirata, and T. Miyakawa.
1997.
Mutational analysis of Yap1 protein, an AP-1-like transcriptional activator of Saccharomyces cerevisiae.
FEBS Lett.
416:339-343[Medline].
|
| 24.
|
Wemmie, J. A.,
S. M. Steggerda, and W. S. Moye-Rowley.
1997.
The Saccharomyces cerevisiae AP-1 protein discriminates between oxidative stress elicited by the oxidants H2O2 and diamide.
J. Biol. Chem.
272:7908-7914[Abstract/Free Full Text].
|
| 25.
|
Wemmie, J. A.,
A.-L. Wu,
K. D. Harshman,
C. S. Parker, and W. S. Moye-Rowley.
1994.
Transcriptional activation mediated by the yeast AP-1 protein is required for normal cadmium tolerance.
J. Biol. Chem.
269:14690-14697[Abstract/Free Full Text].
|
| 26.
|
Wolff, S. P.,
A. Garner, and R. T. Dean.
1986.
Free radicals, lipids and protein degradation.
Trends Biochem. Sci.
11:27-31 |